Global Perspectives on Melanoma, Squamous Cell Carcinoma (SCC), and Basal Cell Carcinoma (BCC)

Expert perspectives on the latest therapeutic developments, treatment approaches, and implications for clinical decision-making regarding melanoma, SCC, and BCC.

November 19, 2022

Faculty Chair

Jeffrey S. Weber, MD, PhD

NYU Langone Medical Center, New York, NY, USA

Faculty Members

Jason Luke, MD
UPMC Hillman Cancer Center, Pittsburgh, PA, USA

Alexander Eggermont, MD, PhD
Princess Máxima, Utrecht, the Netherlands

Axel Hauschild, MD
University of Kiel, Germany

Omid Hamid, MD
The Angeles Clinic and Research Institute, Los Angeles, CA, USA

Reinhard Dummer, MD
University Hospital Zürich, Switzerland

Caroline Robert, MD, PhD
Gustave Roussy, Villejuif, France

Agenda

Download the meeting agenda

View Agenda

KEY TAKEAWAYS AND STRATEGIC INSIGHTS

  • Prognostic and Predictive Markers in Melanoma
  • Adjuvant and Neoadjuvant Therapies in Melanoma: What Is New There?
  • Evolution of Immunotherapy for First-Line Metastatic Melanoma
  • Emerging Insights in Relapsed/Refractory Metastatic Melanoma
  • BRAF-Mutated Melanoma – New Developments or Stagnation?
  • New Perspectives in the Management of SCC

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.